Application of DNA technology to regulate the transcription of disease-related genes has important therapeutic potential. The transcription factor NFkB plays a pivotal role in the transactivation of inflammatory and adhesion molecule genes, leading to vascular lesion formation. Double-stranded DNA with high affinity for NFkB may be introduced as 'decoy' cis elements to bind NFkB and block the activation of genes mediating inflammation, resulting in effective drugs for treating intimal hyperplasia. In this study, we tested the feasibility of NFkB decoy therapy to treat neointimal formation in a porcine coronary artery balloon injury model as a pre-clinical study.
Introduction
Intimal hyperplasia is the pathological process that underlies restenosis, atherosclerosis and vascular graft occlusion, and develops in large part as a result of vascular smooth muscle cell (VSMC) proliferation and migration. 1 A number of logical assumptions about the cellular mechanisms involved in this hyperplastic response have led to clinical trials of various therapeutic approaches to prevent or retard this process. Unfortunately, none of the interventions tested to date has proven to have clinical utility, despite their effectiveness in animal experiments. 2 This discrepancy between expectations and clinical results indicates that the biology of arterial hyperplasia in response to injury may be considerably more complex than originally perceived. Therefore, it is necessary to further investigate the fundamental cellular mechanisms involved in this response, and continue to seek information about targets for treatment of restenosis.
One of the key events in the process of restenosis is migration and accumulation of blood-derived cells such as macrophages. In vascular cells, NFkB has been shown to regulate the expression of vascular adhesion molecule-1 (VCAM-1) and intracellular adhesion molecule-1 (ICAM-1) as a part of the inflammatory response. [3] [4] [5] It is also known that neutralizing antibody to ICAM-1 inhibits intimal hyperplasia after balloon injury of the carotid artery in rats. 6 In situ detection of nuclear p65 and p50 has revealed NFkB activity within human atheroma, eg, in intimal VSMC but not in undiseased arteries. 7, 8 Moreover, NFkB was induced in VSMC after arterial balloon injury. 9, 10 NFkB activity appears to be essential for the proliferation of VSMC, which was demonstrated by the selective inhibition of VSMC growth after transfer of the NFkB inhibitor protein IkBa in cultured VSMC. [11] [12] [13] Recently, decoy DNAs that block the activation of genes mediating inflammation can be effective drugs in treating cardiovascular diseases that involve abnormal growth. To evaluate the therapeutic benefit of inhibition of NFkB in neointimal formation after balloon injury, we utilized synthetic double-stranded DNA with high affinity for NFkB as a 'decoy' cis element to bind the transcription factor and to block the activation of genes. 14, 15 Previous studies have established that NFkB binds with high specificity and affinity to a doublestranded ODN containing a unique consensus sequence. [16] [17] [18] [19] [20] Indeed, transfection of a decoy cis element to bind NFkB resulted in the prevention of intimal hyperplasia in response to vascular injury in a rat carotid artery model, accompanied by a reduction of mRNA of ICAM and VCAM. 18 However, no report has documented the usefulness of an NFkB decoy strategy to prevent restenosis after angioplasty in a porcine model, leading toward human therapy. Thus, we employed a porcine coronary artery balloon injury model to test the feasibility of NFkB decoy therapy as a pre-clinical study. Here, this study demonstrated the feasibility of the 'decoy' strategy against NFkB in the treatment of restenosis after angioplasty.
Results
Effect of hydrogel catheter delivery system in porcine coronary artery model First, we performed in vivo transfer of FITC-labeled NFkB decoy ODN into injured porcine coronary arteries using a hydrogel catheter (Figure 1 ). Transfection of NFkB decoy ODN was performed immediately after balloon inflation, followed by angioplasty. Direct application of 'naked' FITC-labeled NFkB ODN (150 mM; 1 mg/animal) into injured porcine coronary arteries using a hydrogel balloon catheter resulted in fluorescence in the medial layer at 1 day after transfection (Figure 1 ). The fluorescence was localized primarily in cell nuclei, and some could be detected in the deep area of the vessel wall ( Figure 1 ). These findings established the feasibility of using NFkB decoy ODN with a hydrogel catheter delivery approach to treat vascular disease. Untreated vessels or vessels transfected with non-FITClabeled NFkB decoy ODN revealed no specific fluorescence (except auto-fluorescence) in the elastic lamina. Fluorescence resulting from FITC-labeled NFkB decoy ODN was easily distinguished from background autofluorescence. Intraluminal incubation of free FITC did not result in specific fluorescence in the vessel wall, demonstrating that this fluorescence was specific for FITC-labeled ODN.
Efficacy of NFkB decoy strategy for prevention of neointimal formation Thus, we examined the effect of an in vivo anti-gene strategy using NFkB decoy ODN in the porcine coronary artery balloon injury model. First, we examined the effects of NFkB decoy ODN on VSMC proliferation using PCNA staining. As shown in Figure 2a These results may explain the mechanisms of the inhibitory effect of NFkB decoy ODN on neointimal thickening after balloon injury, given that migration of macrophages and lymphocytes plays a pivotal role in the development of restenosis after balloon injury. Finally, we evaluated the effects of NFkB decoy ODN on neointimal formation using hematoxylin-eosin staining ( Figure 4 ). Of importance, a single transfection of NFkB decoy ODN into balloon-injured vessels resulted in a significant decrease in the ratio of neointimal to medial area in blood vessels transfected with NFkB decoy ODN as compared to that in vessels transfected with scrambled decoy ODN at 4 weeks after balloon injury (Figure 4b , Po 0.05). In contrast, there was no significant difference in the medial area between the blood vessels transfected with scrambled and NFkB decoy ODN (data not shown). In addition, we evaluated the vascular structure of porcine coronary arteries using IVUS. The vessels treated with scrambled decoy ODN exhibited a typical image of neointima within the coronary arteries, whereas little neointima could be detected in vessels transfected with NFkB decoy ODN. As shown in Figure 5a , the vessels treated with scrambled decoy ODN exhibited a typical image of neointima within the coronary arteries using IVUS, whereas little neointima could be detected in vessels transfected with NFkB decoy ODN. NFkB decoy ODN, introduced in vivo via a hydrogel catheter (n¼5), inhibited neointimal formation in contrast to vessels transfected with scrambled ODN (n¼5) (Figure 5c , Po0.01). The degree of inhibition of neointimal area by NFkB decoy ODN reached almost 80% (scrambled decoy: 23% versus NFkB decoy: 6%). The selectivity of the effect of NFkB decoy ODN was further confirmed by the demonstration that the inhibition of neointimal 
Discussion
Synthetic double-stranded ODN as 'decoy' cis elements block the binding of nuclear factors to promoter regions of targeted genes, resulting in the inhibition of gene transactivation. 14, 15 We and others have documented the potential utility of a decoy strategy to treat various diseases. One important target for the decoy strategy is the essential transcription factor, NFkB. The family of various complexes of NFkB transcription factor plays an important role in the transcription of a variety of genes, primarily those related to inflammation, interleukins, adhesion molecules, etc. 21, 22 The NFkB complex is a heterodimer of two subunits, p50 and p65. In its inactive form in the cytoplasm, the complex is associated with an inhibitory subunit, IkB. Subunit p65 has the capacity for potent transactivation of target genes and is able to bind IkB. 23, 24 NFkB is activated by a variety of cytokines, endotoxins and oxidative stress. On activation, NFkB dissociates from its inhibitor, IkB, translocates to the nucleus and initiates transcription of various genes for cytokines, and growth and differentiation factors. Numerous genes driven by NFkB, ie, interleukin-1 and -6, TNF-a and leukocyte adhesion molecules, 25 are involved in immune and inflammatory responses. Indeed, we have previously reported that inhibition of NFkB activity by decoy abolished the transactivation of IL-1 and IL-6 under TNF-a stimulation in human aortic endothelial cells. 19 Similarly, in cultured VSMC, inhibition of NFkB by transfer of purified IkB inhibited not only VSMC proliferation but also their migration and adhesion. [26] [27] [28] Recently, it was reported that the increase in nuclear binding of NFkB was transient (peak at 6 h after injury) and had returned to the control level at 3 days after injury. 29 Thus, inhibition of transient NFkB activation should be a new therapeutic strategy. To block NFkB activation, we utilized a 'decoy' cis element, since decoy ODN can bind NFkB and thereby block its activation. 
Inhibition of neointimal formation by NFkB activation K Yamasaki et al
Using this technology, we have already reported the successful inhibition of NFkB activation in a rat carotid artery balloon injury model. 18 Expectedly, neointimal formation in rat injured vessels was successfully inhibited by NFkB, but not scrambled, decoy ODN in vivo, accompanied by the inhibition of Inhibition of neointimal formation by NFkB activation K Yamasaki et al activation of NFkB. 18 We found that inhibition of NFkB activity resulted in potent inhibition of the expression of adhesion molecules such as ICAM and VCAM after injury. Moreover, previous data demonstrated that transfection of NFkB, but not scrambled, decoy ODN significantly inhibited the migration and accumulation of macrophages and T-lymphocytes in the neointima following balloon injury. However, recent studies clearly demonstrated that the rat balloon injury model is not adequate for considering human restenosis. From this viewpoint, the porcine balloon injury model is believed to be ideal. Thus, in this study, we examined the feasibility of NFkB decoy ODN to inhibit restenosis after angioplasty in the porcine coronary artery balloon injury model. To carry out transfection in this model, we employed direct ODN transfer using a hydrogel balloon catheter. First, we investigated the possibility that arterial gene transfer might be performed during balloon angioplasty by delivery of 'naked' ODN from the hydrogel polymer coating of a standard angioplasty balloon. The hydrogel polymer was originally designed to facilitate advancement of the balloon through tight vascular obstructions. The present data demonstrated a relatively wide distribution of NFkB decoy ODN into balloon-injured porcine coronary arteries. Although the transfection efficiency was low as compared to other viral delivery methods, this should be overcome by using an increased amount of ODN. (In this study, we used at least a 100-fold greater amount of ODN in the porcine model.) Similar to DNA transfer, a typical fluorescence pattern specific for FITC-labeled decoy ODN was observed in cells found predominantly in the subintimal and occasionally in the intimal and medial layers. These experiments demonstrated the feasibility of decoy ODN transfer by hydrogel catheter into ballooninjured blood vessels.
The specificity of the inhibitory effect of 'decoy' ODN against NFkB on neointimal formation is supported by several lines of evidence: (1) NFkB decoy ODN almost completely inhibited VSMC proliferation as assessed by two different methods (histological examination and IVUS), whereas scrambled ODN did not, and (2) the reduction of neointimal formation was limited to the area transfected with NFkB decoy ODN. In addition, cell proliferation may be inhibited by NFkB decoy ODN. Our present data demonstrated that NFkB decoy ODN inhibited the increase in PCNA-positive cells induced by angioplasty. Since the p65 component of NFkB has been reported to mutually repress p53 transcription, 30 it is probable that inhibition of NFkB activity enhances p53, an anti-oncogene, in neointimal VSMC. This observation is consistent with recent in vitro experiments showing that NFkB regulates induction of apoptosis in VSMC. [26] [27] [28] In addition, we found that inhibition of NFkB activity resulted in potent inhibition of the expression of adhesion molecules such as ICAM after injury. Since a recent paper reported the inhibitory effect of ICAM antibody on neointimal thickening following balloon injury, 6 the inhibitory effect of NFkB decoy ODN might be due to a decrease in targeted genes, especially ICAM. Moreover, we investigated the migration of macrophages after injury, as migration of these cells is believed to be mediated by ICAM expression. Importantly, the present data demonstrated that transfection of NFkB, but not scrambled, decoy ODN significantly inhibited the migration and accumulation of macrophages in the neointima following balloon injury. Inhibition of VSMC proliferation is suggested to contribute to vascular wound regression, in addition to the inhibition of local inflammatory changes.
Here, we demonstrated that in vivo transfection of NFkB decoy ODN into balloon-injured blood vessels effectively suppressed neointimal formation in a porcine coronary artery model. Although the minipig model is still far from a clinical setting, we believe that therapy using NFkB decoy ODN is feasible for two reasons. First, and perhaps most critical in the case of arterial therapy, is the potential requirement to maintain an optimally high and local concentration over time. It is conceivable, though as yet unproven, that such local transfection of decoy may be preferable, from the standpoints of both safety and efficacy. Second, there is the matter of economics; namely, conservative therapy would ultimately cost more to develop, implement, and reimburse, particularly for those indications requiring multiple or protracted treatment. Although further studies are necessary to enhance cell targeting and modify the ODN composition to prolong decoy stability in vivo, development of an NFkB decoy strategy offers great promise as a new tool for defining biological processes and treating pathological conditions. Recent progress in drug-eluting stents seems to provide a new therapeutic modality as gene therapy against restenosis after angioplasty. Currently, rapamycin or taxotel have been used in clinical trials. In addition to those classical pharmacological drugs, in vivo transfection of a 'decoy' cis element to bind the critical transcription factor NFkB with stent may have the therapeutic values. Currently, we have started to treat restenosis after angioplasty in human patients from August 2001, based on the present study. Future human trials may provide more information about the clinical utility of NFkB decoy ODN.
Materials and methods

Synthesis of ODN
Sequences of the phosphorothioate ODN utilized were as follows: NFkB decoy ODN (consensus sequences are underlined; 16-20 5 0 -CCTTGAAGGGATTTCCCTCC-3
NFkB decoy ODN have been shown to bind the NFkB transcription factor. [16] [17] [18] [19] [20] Synthetic ODN were washed with 70% ethanol, dried and dissolved in sterile Tris-EDTA buffer (10 mM Tris, 1 mM EDTA). The supernatant was purified over a NAP 10 column (Pharmacia, Piscataway, NI, USA) and quantified by spectrophotometry.
Experimental design
Male Gottingen miniature pigs weighing 18-23 kg were housed individually under controlled room temperature and fed laboratory chow. These pigs were lightly anesthetized with intramuscular ketamine hydrochloride (12.5 kg/kg) followed by intravenous administration of pentobarbital sodium (20 mg/kg). They were intubated and ventilated with a positive pressure respirator. The femoral artery was surgically exposed, and a cannula was introduced into the orifice of the left coronary artery over a guide wire. 31 Before insertion of the catheter, heparin (5000 IU) was intravenously injected. A balloon catheter (length 2 cm; balloon size 2.5 or 3.0 mm; Boston Scientific Com., MA, USA) was placed in the left ascending coronary artery over the guide wire under angiographic guidance. Then, the endothelium was mechanically denuded by inflation at a B/A ratio of 1.2 (diameter of inflated balloon/diameter of reference segment) under intravascular ultrasound (IVUS; CVIS, 2.6 Fr.). Balloon inflation was performed three times at 6 atm under angiography to dilate the blood vessels to 1:1.2. The pigs were divided into two groups and treated with NFkB or scrambled decoy ODN (1 mg/pig) using a hydrogel catheter (HydroPlus, Boston Scientific Com.) immediately after balloon injury, followed by angioplasty. Transfection of NFkB decoy ODN using a single inflation of the hydrogel catheter was performed once without any vector at 6 atm for 90 s. After angioplasty, heparin (100 U/kg) and nitroglycerin (0.1 mg/animal) were intra-arterially administered to avoid thrombosis. No adverse neurological or vascular effects were observed in any animal undergoing this procedure. At 4 weeks after operation, the animals were killed after the measurement of coronary artery size by IVUS.
In vivo transfection of FITC-labeled NFkB decoy ODN
FITC-labeled NFkB decoy ODN were provided by Nihon Seifun (Tochigi, Japan). The 3' and 5' ends of the ODN were labeled with FITC. Transfection procedures were as described above. The vessels were harvested 1 day after transfection and perfusion-fixed with 4% paraformaldehyde. Sections were examined by fluorescent microscopy, after staining in Eriochrome Black T solution. Elastic fibers stain dark red and are readily distinguishable from the specific FITC-labeled ODN after treatment with Eriochrome Black T solution. 32 
Histological studies
For histological analyses, a segment of each artery was fixed with 4% paraformaldehyde. Medial and luminal areas were measured on a digitizing tablet after staining with hematoxylin. 6, 33 The medial area was readily demarcated as the vessel area between the internal and external elastic laminae. At least three individual sections from the middle of the transfected arterial segments were analyzed. Animals were coded so that the analysis was performed without knowledge of which treatment each individual animal had received.
Immunohistochemistry against ICAM (goat IgG, Santa Cruz Co. LTd., CA, USA) and macrophages (mouse IgG, DAKO) was performed. Sections from 4-6 animals (each group at each time points) were dewaxed, rehydrated, and incubated with PBS containing 0.3% hydrogen peroxide to reduce endogenous peroxidase activity. The sections were then incubated with primary antibodies or lectin, diluted in PBS with 10% horse serum, at room temperature for 60 min. After washing three times in Tris-buffered saline containing 2% horse serum, speciesappropriate biotinylated secondary antibodies were applied followed by avidin-biotin peroxidase complex (Vectastain ABC kit, PK 6100, Vector Laboratories, CA, USA). Antibody binding was visualized with diaminobenzidine. Omission of primary antibodies and staining with type-and class-matched irrelevant immunoglobulin served as a negative control for each antibody.
IVUS measurement
Selective cine angiography (12 images/s) was performed before and after intervention and at follow-up, with a digital C-arm (Philips). The image with the highest contrast was selected and stored on digital audiotape for later analysis. IVUS recordings were also made before and after intervention and at follow-up, with a 30-MHz ultrasound transducer, 33 which rotated up to 16 times per second within the 4 F catheter. The axial resolution of the system was 0.1 mm. The images were recorded on VHS videotape and later analyzed with a digital video analyzer. In the IVUS images, the area circumscribed by the interface between the echodense intimal layer and the echolucent media was traced manually and taken as the media-bounded area (MBA). In addition, the lumen area (LA) was traced and the minimum lumen area was determined. At follow-up, the plaque area was taken as the difference between MBA and the lumen area.
Statistical analysis
All values are expressed as mean7SEM. Analysis of variance with subsequent Bonferroni/Dunnet's test was employed to determine the significance of differences in multiple comparisons. Values of Po0.05 were considered statistically significant.
